Insulin promotes de novo lipogenesis (DNL), which increases hepatic synthesis of palmitic acid and consequently the risk of lipotoxicity, resulting in hepatocyte apoptosis and NAFLD progression [6,7]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.